Thiogenesis Therapeutics, Corp.
TTI.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -35.55% | -21.58% | -12.88% | -15.47% | -10.98% |
| Total Receivables | -10.55% | -34.86% | 12.32% | 56.32% | -50.71% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.86% | 29.00% | 35.66% | -28.24% | -32.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -34.73% | -21.26% | -12.07% | -14.91% | -11.91% |
|
|
|||||
| Total Current Assets | -34.73% | -21.26% | -12.07% | -14.91% | -11.91% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -34.73% | -21.26% | -12.07% | -14.91% | -11.91% |
|
|
|||||
| Total Accounts Payable | 60.14% | 75.21% | 394.52% | -65.22% | -11.43% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 57.36% | 78.31% | 394.52% | -65.22% | -11.43% |
|
|
|||||
| Total Current Liabilities | 57.36% | 78.31% | 394.52% | -65.22% | -11.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 57.36% | 78.31% | 394.52% | -65.22% | -11.43% |
|
|
|||||
| Common Stock & APIC | 5.39% | 0.58% | -3.31% | 1.39% | -1.06% |
| Retained Earnings | -18.14% | -9.99% | -1.93% | -6.63% | -4.38% |
| Treasury Stock & Other | 19.48% | 3.16% | -9.69% | 3.57% | 3.05% |
| Total Common Equity | -77.50% | -37.47% | -22.46% | -11.64% | -11.94% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -77.50% | -37.47% | -22.46% | -11.64% | -11.94% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -77.50% | -37.47% | -22.46% | -11.64% | -11.94% |
|
|
|||||